FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...

FDA-approved as the first and only approved first line treatment for advanced squamous cell carcinoma of the anal canal.

A preliminary Congressional Budget Office analysis said that a Republican legislative proposal that makes changes to Medicaid ...

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

The S&P 500 climbed by 2.8% on Monday, May 12, 2025 as investors reviewed the trade deal between the U.S. and China that ...

A measure now on the floor of the Nebraska Legislature would address some practices by intermediaries called pharmacy benefit managers that pharmacists say are harming their businesses.

A White House official said on a press call early Monday that a new executive order from President Trump will push drugmakers ...

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial. Lilly ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

Omada Health, a virtual chronic care provider, filed to go public Friday, marking the second digital health company making ...

Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss ... patients cannot afford to pay for on their own. The formulary is maintained by CVS ...

Pharmacology has been at it a long time. Precursor to the Western pill-based prescription for all that ails, it stands on the shoulders of a thousands-generations long compilation of the knowledge of ...